A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

A New Zealand bariatric surgeon cautions that Wegovy, a new weight-loss drug, isn't a magic bullet for obesity. While it can trigger initial weight loss, long-term success hinges on lifestyle changes ...

Novo Nordisk NVO announced that it has submitted a regulatory application to the European Medicines Agency (EMA) seeking ...

The move follows a dramatic breakup in June between Hims & Hers and Danish drug maker Novo Nordisk, which makes the brand name weight loss drug Wegovy. Novo Nordisk accused the Hims & Hers of ...

The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.

Skye’s Nimacimab shows promise in obesity treatment with lean mass preservation. Phase 2a results slated for 2025 could drive ...